| TUBB3 reverses resistance to docetaxel and cabazitaxel in prostate cancer Y Sekino, X Han, T Kawaguchi, T Babasaki, K Goto, S Inoue, T Hayashi, ... International journal of molecular sciences 20 (16), 3936, 2019 | 52 | 2019 |
| Microtubule-associated protein tau (MAPT) promotes bicalutamide resistance and is associated with survival in prostate cancer Y Sekino, X Han, T Babasaki, K Goto, S Inoue, T Hayashi, J Teishima, ... Urologic Oncology: Seminars and Original Investigations 38 (10), 795. e1-795. e8, 2020 | 30 | 2020 |
| PTEN is involved in sunitinib and sorafenib resistance in renal cell carcinoma Y Sekino, T Hagura, X Han, T Babasaki, K Goto, S Inoue, T Hayashi, ... Anticancer research 40 (4), 1943-1951, 2020 | 28 | 2020 |
| Microtubule-associated protein tau (MAPT) is a promising independent prognostic marker and tumor suppressive protein in clear cell renal cell carcinoma X Han, Y Sekino, T Babasaki, K Goto, S Inoue, T Hayashi, J Teishima, ... Urologic Oncology: Seminars and Original Investigations 38 (6), 605. e9-605. e17, 2020 | 26 | 2020 |
| TUBB3 is associated with high-grade histology, poor prognosis, p53 expression, and cancer stem cell markers in clear cell renal cell carcinoma Y Sekino, X Han, T Babasaki, S Miyamoto, H Kitano, G Kobayashi, K Goto, ... Oncology 98 (10), 689-698, 2020 | 24 | 2020 |
| BUB1B overexpression is an independent prognostic marker and associated with CD44, p53, and PD-L1 in renal cell carcinoma Y Sekino, X Han, G Kobayashi, T Babasaki, S Miyamoto, K Kobatake, ... Oncology 99 (4), 240-250, 2021 | 20 | 2021 |
| Magnetic resonance imaging/transrectal ultrasonography fusion targeted prostate biopsy finds more significant prostate cancer in biopsy‐naïve Japanese men compared with the … S Fujii, T Hayashi, Y Honda, H Terada, R Akita, N Kitamura, E Ueda, ... International Journal of Urology 27 (2), 140-146, 2020 | 18 | 2020 |
| TUBB3 is associated with PTEN, neuroendocrine differentiation, and castration resistance in prostate cancer Y Sekino, X Han, T Babasaki, S Miyamoto, K Kobatake, H Kitano, K Ikeda, ... Urologic Oncology: Seminars and Original Investigations 39 (6), 368. e1-368. e9, 2021 | 9 | 2021 |
| Therapeutic resistance models and treatment sequencing in advanced prostate cancer ZA Schaaf, S Ning, AR Leslie, M Sharifi, X Han, C Armstrong, W Lou, ... Cancers 15 (21), 5273, 2023 | 2 | 2023 |
| Supplementary Material for: BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma Y Sekino, X Han, G Kobayashi, T Babasaki, S Miyamoto, K Kobatake, ... (No Title), 2021 | | 2021 |
| MP18-18 P53 IS INVOLVED IN RESISTANCE TO SUNITINIB IN RENAL CELL CARCINOMA Y Sekino*, X Han, K Goto, S Inoue, T Hayashi, J Teishima, T Daiki, ... The Journal of Urology 203 (Supplement 4), e242-e242, 2020 | | 2020 |
| MP70-19 MAGNETIC RESONANCE IMAGING-TRANSRECTAL ULTRASOUND IMAGE FUSION BIOPSIES IMPROVED ACCURATE IDENTIFICATION OF THE INDEX TUMOR AT RADICAL PROSTATECTOMY SPECIMENS T Hayashi, S Fujii, S Miyamoto, X Han, K Ikeda, S Inoue, J Teishima, ... Journal of Urology 203, e1062, 2020 | | 2020 |
| Supplementary Material for: TUBB3 Is Associated with High-Grade Histology, Poor Prognosis, p53 Expression, and Cancer Stem Cell Markers in Clear Cell Renal Cell Carcinoma Y Sekino, X Han, T Babasaki, S Miyamoto, H Kitano, G Kobayashi, K Goto, ... (No Title), 2020 | | 2020 |
| COMPARISON BETWEEN MRI/TRUS FUSION TARGETED PROSTATE BIOPSY AND CONVENTIONAL SYSTEMATIC BIOPSY S FUJII, T HAYASHI, X HAN, S MIYAMOTO, MAI OKAZAKI, S TASAKA, ... 西日本泌尿器科 82 (2), 234-241, 2020 | | 2020 |
